Kura Oncology (KURA) Total Debt (2014 - 2026)

Kura Oncology (KURA) has 12 years of Total Debt data on file, last reported at $9.7 million in Q1 2026.

• On a quarterly basis, Total Debt rose 1.86% year-over-year to $9.7 million in Q1 2026; TTM through Mar 2026 was $9.7 million, a 1.86% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 1.97% from the prior year.
• Total Debt for Q1 2026 stood at $9.7 million, roughly flat from $9.7 million in the prior quarter.
• Over the last five years, Total Debt for KURA reached as high as $9.7 million in Q1 2026 and fell as low as $9.2 million in Q4 2022.
• Historically, Total Debt has averaged $9.5 million across 5 years, with a median of $9.4 million in 2024.
• Across the five-year window, Total Debt rose 2.12% in 2025 and increased 1.86% in 2026, its largest moves.
• Year by year, Total Debt stood at $9.2 million in 2022, then climbed by 1.9% to $9.3 million in 2023, then grew by 2.05% to $9.5 million in 2024, then increased by 1.97% to $9.7 million in 2025, then climbed by 0.39% to $9.7 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $9.7 million in Q1 2026, $9.7 million in Q4 2025, and $9.7 million in Q3 2025.